首页 > 市场调查报告书 > 医疗设备

整形外科

市场调查报告书

商品编码

1424386

全球掌腱膜挛缩症市场：依疾病类型、类型、最终用户、地区

Global Dupuytren's Disease Market, By Disease Type, By Type (Diagnosis and Treatment), By End User, By Geography

出版日期: 2024年01月08日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2023年，全球掌腱膜挛缩症市场规模为43亿美元，预估2023年至2030年复合年成长率为4.6%，2030年达59亿美元。

掌腱膜挛缩症是一种影响掌筋膜的疾病，掌筋膜是位于皮肤下方并覆盖手掌和手掌的肌腱、神经、血管和骨骼的一层纤维组织。掌腱膜挛缩症患者的筋膜会随着时间的推移而增厚和收缩（缩短）。在此过程中，筋膜可能会拉动手指，迫使它们进入手掌内部。结果，伸直手指可能会变得困难或不可能，称为掌腱膜挛缩。随着掌腱膜挛缩的恶化，它会影响手部功能并使某些人的日常生活变得困难。在这种情况下，可以采用非手术和手术治疗方法来减缓疾病的进展（恶化）并改善受影响手指的活动。掌腱膜挛缩的原因尚不清楚。这种疾病往往有家族遗传倾向。男性比女性更常见。掌腱膜挛缩症的挛缩多年来缓慢恶化。这种情况始于手掌上出现硬块。该肿块可能会或可能不会疼痛。随着时间的推移，肿块在皮肤下变成一条硬绳，延伸到手指。这根绳子拉紧手指并将它们拉向手掌，有时甚至很严重。

市场动态：

掌腱膜挛缩症盛行率的增加预计将在预测期内推动全球掌腱膜挛缩症市场的成长。例如，根据公共关係和免费媒体软体公司及服务供应商Cision US Inc. 2022 年 10 月发布的资料，估计北美每年有 1,400 万人受到掌腱膜挛缩症的影响。

本研究的主要特点

本报告对全球掌腱膜挛缩症市场进行了详细分析，并列出了以2022年为基准年的预测期（2023-2030）的市场规模和复合年成长率。
它还强调了各个细分市场的潜在收益成长机会，并为该市场说明了一系列有吸引力的投资提案。
它还提供了有关市场促进因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球掌腱膜挛缩症市场的主要企业。
该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
全球掌腱膜挛缩症市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以透过用于分析全球掌腱膜挛缩症市场的各种策略矩阵来促进决策。

介绍
2023年及2030年市场占有率分析（%）
与前一年同期比较成长分析，2019-2030
细分市场趋势
Ⅰ型
介绍
2018-2030年市场规模及预测、与前一年同期比较成长率
II型
介绍
2018-2030年市场规模及预测、与前一年同期比较成长率
Ⅲ型
介绍
2018-2030年市场规模及预测、与前一年同期比较成长率

第6章全球掌腱膜挛缩症市场，依类型，2018-2030

介绍
2023年及2030年市场占有率分析（%）
与前一年同期比较成长分析，2019-2030
细分市场趋势
诊断
介绍
2018-2030年市场规模及预测、与前一年同期比较成长率
体检
X光
流程
介绍
2018-2030年市场规模及预测、与前一年同期比较成长率
外科手术
放射治疗
针腱膜切开术
类固醇注射
酵素注射液
职能治疗
其他

第 7 章全球掌腱膜挛缩症市场，依最终使用者分类，2018-2030 年

介绍
2023年及2030年市场占有率分析（%）
与前一年同期比较成长分析，2019-2030
细分市场趋势
医院
介绍
2018-2030年市场规模及预测、与前一年同期比较成长率
诊所
介绍
2018-2030年市场规模及预测、与前一年同期比较成长率
学术/研究机构
介绍
2018-2030年市场规模及预测、与前一年同期比较成长率
其他
介绍
2018-2030年市场规模及预测、与前一年同期比较成长率

第8章全球掌腱膜挛缩症市场，按地区，2018-2030

介绍
2023 年和 2030 年按国家/地区分类的市场占有率分析 (%)
2019-2030与前一年同期比较成长分析（按国家）
各国的趋势
北美洲
介绍
2018-2030年市场规模及依疾病类型预测、与前一年同期比较成长率
2018-2030年市场规模及按类型预测、与前一年同期比较成长率
2018-2030 年市场规模与最终用户预测、与前一年同期比较成长率
2018-2030 年市场规模与预测（按国家）、与前一年同期比较成长率（按国家）
美国
加拿大
欧洲
介绍
2018-2030年市场规模及依疾病类型预测、与前一年同期比较成长率
2018-2030年市场规模及按类型预测、与前一年同期比较成长率
2018-2030 年市场规模与最终用户预测、与前一年同期比较成长率
2018-2030 年市场规模与预测（按国家）、与前一年同期比较成长率（按国家）
英国
德国
义大利
法国
西班牙
俄罗斯
欧洲其他地区
亚太地区
介绍
2018-2030年市场规模及依疾病类型预测、与前一年同期比较成长率
2018-2030年市场规模及按类型预测、与前一年同期比较成长率
2018-2030 年市场规模与最终用户预测、与前一年同期比较成长率
2018-2030 年市场规模与预测（按国家）、与前一年同期比较成长率（按国家）
中国
印度
日本
东南亚国协
澳洲
韩国
其他亚太地区
拉丁美洲
介绍
2018-2030年市场规模及依疾病类型预测、与前一年同期比较成长率
2018-2030年市场规模及按类型预测、与前一年同期比较成长率
2018-2030 年市场规模与最终用户预测、与前一年同期比较成长率
2018-2030 年市场规模与预测（按国家）、与前一年同期比较成长率（按国家）
巴西
墨西哥
阿根廷
其他拉丁美洲
中东
介绍
2018-2030年市场规模及依疾病类型预测、与前一年同期比较成长率
2018-2030年市场规模及按类型预测、与前一年同期比较成长率
2018-2030 年市场规模与最终用户预测、与前一年同期比较成长率
2018-2030 年按国家/与前一年同期比较的市场规模和预测、按国家/地区分类的同比成长率
海湾合作理事会国家
以色列
其他中东地区
非洲
介绍
2018-2030年市场规模及依疾病类型预测、与前一年同期比较成长率
2018-2030年市场规模及按类型预测、与前一年同期比较成长率
2018-2030 年市场规模与最终用户预测、与前一年同期比较成长率
2018-2030年按国家/地区、与前一年同期比较成长率和国家分类的市场规模和预测
北非
中部非洲
南非

第9章竞争形势

Endo International Plc
Bristol-Meyers Squibb Company
Spear Pharmaceuticals
GSK Plc.
AstraZeneca
Hikma Pharmaceuticals Plc
LEO Pharma A/S
Fresenius Kabi AG
Bayer AG
Novartis AG
Pfizer Inc.
Nantong Jinghua Pharmaceutical Co., Ltd.
Actiza Pharmaceutical Pvt. Ltd.

第10章

调查方法
关于出版商

简介目录

Product Code: CMI6530

The global Dupuytren's disease market size is valued at US$ 4.3 Bn in 2023 and is expected to reach US$ 5.9 Bn by 2030, growing at a compound annual growth rate (CAGR) of 4.6% from 2023 to 2030.

Dupuytren's disease is a condition that affects the palmar fascia - the fibrous layer of tissue that lies underneath the skin and above the tendons, nerves, blood vessels, and bones in the palm and fingers. In patients with Dupuytren's disease, the fascia thickens and contracts (shortens) over time. The fascia may pull on the fingers during this process, causing them to be forced inward, toward the palm. This may make it difficult or impossible to fully straighten the fingers, resulting in what is known as a "Dupuytren's contracture." In some people, a worsening Dupuytren's contracture can interfere with hand function, making it difficult to perform daily activities. When this occurs, there are non-surgical and surgical treatment options available to help slow the progression (worsening) of the disease and improve motion in the affected fingers. The cause of Dupuytren contracture is unknown. The condition tends to run in families. It is more common in men than in women. Dupuytren contracture gets worse slowly, over years. The condition begins with a firm lump in the palm of the hand. This lump can be painful or painless. Over time, the lump can extend into a hard cord under the skin and up into the finger. This cord tightens and pulls the finger toward the palm, sometimes severely.

Market Dynamics:

The increasing prevalence of Dupuytren's disease is expected to drive the growth of the global Dupuytren's disease market over the forecast period. For instance, according to data published in October 2022 by Cision US Inc., a public relations and earned media software company and services provider, an estimated 14 million people are affected by Dupuytren's disease every year in North America.

Key features of the study:

This report provides an in-depth analysis of the global Dupuytren's disease market, and provides market size (US$ Bn ) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global Dupuytren's disease market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Endo International Plc, Bristol-Meyers Squibb Company, Spear Pharmaceuticals, GSK Plc., AstraZeneca, Hikma Pharmaceuticals Plc, LEO Pharma A/S, Fresenius Kabi AG, Bayer AG, Novartis AG, Pfizer Inc., Nantong Jinghua Pharmaceutical Co., Ltd., and Actiza Pharmaceutical Pvt. Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global Dupuytren's disease market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Dupuytren's disease market

Detailed Segmentation:

Global Dupuytren's Disease Market Segmentation, By Disease Type:
Type I
Type II
Type III
Global Dupuytren's Disease Market Segmentation, By Type:
Diagnosis
Physical Examination
X-ray
Treatment
Surgery
Radiation Therapy
Needle Aponeurotomy
Steroid Shot
Enzyme Injection
Occupational Therapy
Others
Global Dupuytren's Disease Market Segmentation, By End User:
Hospitals
Clinics
Academic & Research Institute
Others
Global Dupuytren's Disease Market Segmentation, By Region:
North America
Europe
Asia Pacific
Latin America
Middle East
Africa
Company Profile:
Endo International Plc
Bristol-Meyers Squibb Company
Spear Pharmaceuticals
GSK Plc.
AstraZeneca
Hikma Pharmaceuticals Plc
LEO Pharma A/S
Fresenius Kabi AG
Bayer AG
Novartis AG
Pfizer Inc.
Nantong Jinghua Pharmaceutical Co., Ltd.
Actiza Pharmaceutical Pvt. Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
Market Definition and Scope
Executive Summary
Market Dupuytren's Disease , By Disease Type
Market Dupuytren's Disease , By Type
Market Dupuytren's Disease , By End User
Market Dupuytren's Disease , By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Drivers
Increasing prevalence of Dupuytren's disease
Restraints
High cost of treatment
Opportunities
Emerging economies
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Dupuytren's Disease Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Dupuytren's Disease Market, By Disease Type, 2018-2030, (US$ Bn)

Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019 - 2030
Segment Trends
Type I
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Type II
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Type III
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global Dupuytren's Disease Market, By Type, 2018-2030, (US$ Bn)

Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019 - 2030
Segment Trends
Diagnosis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Physical Examination
X-ray
Treatment
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Surgery
Radiation Therapy
Needle Aponeurotomy
Steroid Shot
Enzyme Injection
Occupational Therapy
Others

7. Global Dupuytren's Disease Market, By End User, 2018-2030, (US$ Bn)

Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2019 - 2030
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Academic & Research Institute
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Global Dupuytren's Disease Market, By Region, 2018-2030, (US$ Bn)

Introduction
Market Share Analysis, By Country, 2023 and 2030 (%)
Y-o-Y Growth Analysis, For Country, 2019 - 2030
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
Market Size and Forecast, By Country/Region, Y-o-Y Growth and By Country/Region, 2018 - 2030, (US$ Bn)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Endo International Plc
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Bristol-Meyers Squibb Company
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Spear Pharmaceuticals
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
GSK Plc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
AstraZeneca
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Hikma Pharmaceuticals Plc
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
LEO Pharma A/S
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Fresenius Kabi AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Bayer AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Novartis AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Pfizer Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Nantong Jinghua Pharmaceutical Co., Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Actiza Pharmaceutical Pvt. Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Analyst Views

10. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

全球掌腱膜挛缩症市场：依疾病类型、类型、最终用户、地区